Forrester Research, Inc. (NASDAQ:FORR – Free Report) – Stock analysts at Sidoti Csr lifted their Q2 2025 EPS estimates for Forrester Research in a note issued to investors on Monday, September 30th. Sidoti Csr analyst A. Soderstrom now forecasts that the technology company will earn $0.58 per share for the quarter, up from their prior estimate of $0.57. The consensus estimate for Forrester Research’s current full-year earnings is $0.95 per share. Sidoti Csr also issued estimates for Forrester Research’s FY2025 earnings at $1.13 EPS.
Forrester Research (NASDAQ:FORR – Get Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The technology company reported $0.47 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.09). The company had revenue of $121.83 million during the quarter, compared to the consensus estimate of $121.21 million. Forrester Research had a return on equity of 6.52% and a net margin of 0.32%.
Get Our Latest Analysis on Forrester Research
Forrester Research Stock Down 6.0 %
Shares of NASDAQ:FORR opened at $16.93 on Wednesday. Forrester Research has a 12-month low of $16.14 and a 12-month high of $29.93. The stock has a market capitalization of $323.48 million, a price-to-earnings ratio of 564.33, a PEG ratio of 1.39 and a beta of 0.87. The stock has a fifty day simple moving average of $18.46 and a two-hundred day simple moving average of $18.50. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.15.
Insider Transactions at Forrester Research
In related news, insider Ryan Darrah sold 3,895 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $18.26, for a total transaction of $71,122.70. Following the completion of the sale, the insider now owns 19,640 shares of the company’s stock, valued at $358,626.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 39.20% of the company’s stock.
Institutional Investors Weigh In On Forrester Research
Several institutional investors have recently modified their holdings of the business. Point72 DIFC Ltd raised its position in Forrester Research by 62.4% in the 2nd quarter. Point72 DIFC Ltd now owns 1,713 shares of the technology company’s stock worth $29,000 after buying an additional 658 shares during the last quarter. PNC Financial Services Group Inc. lifted its position in Forrester Research by 52.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,553 shares of the technology company’s stock valued at $42,000 after purchasing an additional 533 shares during the period. State Board of Administration of Florida Retirement System bought a new position in Forrester Research during the first quarter valued at approximately $186,000. Paloma Partners Management Co purchased a new stake in Forrester Research in the first quarter worth approximately $222,000. Finally, Quantbot Technologies LP bought a new stake in Forrester Research in the 1st quarter worth approximately $223,000. 55.20% of the stock is owned by hedge funds and other institutional investors.
Forrester Research Company Profile
Forrester Research, Inc operates as an independent research and advisory company in the United States and internationally. The company operates in three segments: Research, Consulting, and Events. The Research segment primary subscription research services include Forrester Decisions, Forrester Research, and SiriusDecisions Research, which are designed to provide business and technology leaders with a proven path to growth through customer obsession.
Further Reading
- Five stocks we like better than Forrester Research
- Differences Between Momentum Investing and Long Term Investing
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Upcoming IPO Stock Lockup Period, Explained
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Best Stocks Under $10.00
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Forrester Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forrester Research and related companies with MarketBeat.com's FREE daily email newsletter.